Erik G Lund

Title: Erik G Lund: Innovator in Cholesterol Research

Introduction

Erik G Lund is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of cholesterol research through his innovative work. His expertise and dedication have led to advancements that may impact health and biopharmaceutical applications.

Latest Patents

Erik G Lund holds a patent related to cholesterol 25-hydroxylase. The invention provides methods and compositions that involve cholesterol 25-hydroxylase polypeptides with specific structures and activities. It includes related polynucleotides and modulators of cholesterol 25-hydroxylase function and serum cholesterol. The patent also covers isolated cholesterol 25-hydroxylase hybridization probes and primers that can specifically hybridize with natural cholesterol 25-hydroxylase genes. Additionally, it includes specific binding agents such as antibodies, agonists, and antagonists. The methods outlined in the patent are applicable in diagnosis, therapy, and the biopharmaceutical industry.

Career Highlights

Erik G Lund is affiliated with the University of Texas System, where he continues to contribute to research and innovation. His work has garnered attention for its potential applications in medical diagnostics and treatment.

Collaborations

One of his notable collaborators is David W Russell, with whom he has worked on various projects related to cholesterol research.

Conclusion

Erik G Lund's contributions to cholesterol research through his patent on cholesterol 25-hydroxylase highlight his role as an innovator in the field. His work has the potential to influence both therapeutic and diagnostic approaches in healthcare.